 | Krystal Biotech Inc (NASDAQ:KRYS) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - October 15 at 1:36 AM |
| Krystal Biotech Inc (NASDAQ:KRYS) Sees Significant Growth in Short Interest
www.americanbankingnews.com - October 12 at 7:47 PM |
 | BRIEF-Krystal Biotech Receives Positive EMA Opinion On Orphan Designation For KB105
www.msn.com - October 11 at 2:58 AM |
 | Krystal Biotech Receives Positive EMA Opinion on Orphan Designation for KB105 to Treat Patients With TGM1 Deficient Autosomal Recessive Congenital Ichthyosis
finance.yahoo.com - October 10 at 9:04 AM |
| Before You Buy Krystal Biotech, Inc. (NASDAQ:KRYS), Consider Its Volatility
finance.yahoo.com - October 4 at 4:00 PM |
| Krystal Biotech Inc (NASDAQ:KRYS) Expected to Announce Earnings of -$0.39 Per Share
www.americanbankingnews.com - October 2 at 3:15 PM |
| Krystal Biotech (NASDAQ:KRYS) PT Set at $81.00 by Guggenheim
www.americanbankingnews.com - September 30 at 8:06 PM |
| Krystal Biotech to Present at the Cantor 2019 Global Healthcare Conference and Chardan's 3rd Annual Genetic Medicines Conference
finance.yahoo.com - September 30 at 8:23 AM |
| Krystal Biotech Announces Granting of its First Foreign Patent and Reinforces its IP Portfolio with a New U.S. Patent
finance.yahoo.com - September 27 at 5:23 PM |
| Krystal Biotech (NASDAQ:KRYS) Earns Neutral Rating from Analysts at Goldman Sachs Group
www.americanbankingnews.com - September 24 at 8:39 AM |
 | Krystal Biotech: KB-103 Sprints To Become The First Approved Topical Gene Therapy For Skin Disease
seekingalpha.com - September 19 at 11:40 PM |
| Krystal Biotech initiates early-stage study of gene therapy for rare skin disorder
seekingalpha.com - September 4 at 12:05 PM |
| Krystal Biotech Announces Initiation of Phase 1/2 Study of KB105 in Transglutaminase-1 (“TGM1”) Deficient Autosomal Recessive Congenital Ichthyosis (“ARCI”)
finance.yahoo.com - September 4 at 12:05 PM |
| Krystal Biotech Announces Attendance at Citi’s 14th Annual Biotech Conference
finance.yahoo.com - August 27 at 6:03 PM |
| Have Insiders Been Buying Krystal Biotech, Inc. (NASDAQ:KRYS) Shares?
finance.yahoo.com - August 14 at 6:01 PM |
| Krystal Biotech EPS misses by $0.05
seekingalpha.com - August 5 at 9:31 AM |
| Krystal Biotech Reports Second Quarter 2019 Financial and Operating Results
finance.yahoo.com - August 5 at 9:31 AM |
| Krystal Biotech, Inc. Added to the Russell 2000 Index
finance.yahoo.com - July 1 at 9:42 AM |
| Hedge Funds Have Never Been This Bullish On Krystal Biotech, Inc. (KRYS)
finance.yahoo.com - June 27 at 5:22 PM |
 | Whitney Ijem
www.benzinga.com - June 26 at 9:55 AM |
| Krystal Biotech Analyst Lifts Price Target More Than 50% On Positive Phase 2 Data, RMAT Designation
finance.yahoo.com - June 25 at 5:52 PM |
| Krystal Biotech Rallies On Positive Trial Results For Skin Condition
www.benzinga.com - June 25 at 10:02 AM |
| Krystal Biotech up 27% on positive KB103 data in rare skin disorder
seekingalpha.com - June 24 at 5:38 PM |
 | Krystal Biotech shares up 27% after company's skin drug receives expedited review designation from FDA
www.marketwatch.com - June 24 at 5:38 PM |
 | Krystal Biotech Announces Proposed $100 Million Public Offering of Common Stock
www.nasdaq.com - June 24 at 5:38 PM |
 | Krystal Biotech stock jumps after positive clinical trial results
www.bizjournals.com - June 24 at 5:38 PM |
| Krystal Submits Investigational New Drug (IND) Application for KB105, Topical Gene Therapy Candidate for Transglutaminase-1 Deficient Autosomal Recessive Congenital Ichthyosis
finance.yahoo.com - June 14 at 11:33 AM |
| Krystal Biotech (KRYS) Presents At RBC Capital Markets 2019 Healthcare Conference - Slideshow
seekingalpha.com - May 23 at 6:08 PM |
| Krystal Biotech to Present at the RBC Capital Markets 2019 Healthcare Conference
finance.yahoo.com - May 15 at 9:44 AM |
| Krystal Biotech Reports First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 6 at 9:45 AM |
| Biotech News Recap: Upcoming Presentations For Krystal Biotech At SID
seekingalpha.com - April 30 at 9:36 AM |
| Krystal Biotech Announces Five Presentations of Clinical and Preclinical Data at the Society for Investigative Dermatology Annual Meeting
finance.yahoo.com - April 29 at 9:34 AM |
| Krystal Biotech: Game-Changing Gene Therapies For Serious Skin Diseases
seekingalpha.com - March 29 at 6:03 PM |
| EMA Grants PRIME Eligibility for KB103 to Treat Dystrophic Epidermolysis Bullosa
finance.yahoo.com - March 29 at 9:55 AM |
| Krystal Biotech, Inc. Estimate Momentum
www.nasdaq.com - March 21 at 5:18 AM |
| Krystal Biotech Reports 2018 Financial Results and Business Progress
finance.yahoo.com - March 12 at 11:05 AM |
| Krystal (KRYS) in Focus: Stock Moves 5.1% Higher
finance.yahoo.com - March 7 at 10:30 AM |
| Krystal Biotech christens new manufacturing facility for KB103
seekingalpha.com - March 6 at 6:09 PM |
| Krystal Biotech Continues Vertical Integration with Official Inauguration of Ancoris Gene Therapy Manufacturing Facility at its Pittsburgh Headquarters
finance.yahoo.com - March 6 at 9:58 AM |
| Pharma manufacturing center opens in South Side; more jobs lanned
www.msn.com - March 5 at 5:39 PM |
| Krystal Strengthens Board of Directors with Appointment of Julian S. Gangolli
finance.yahoo.com - March 4 at 10:18 AM |
| Krystal Biotech to Present at the Cowen and Company 39th Annual Health Care Conference
finance.yahoo.com - March 1 at 10:08 AM |
| Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference - Nasdaq
www.nasdaq.com - February 23 at 9:34 AM |
| Krystal Biotech: Institutional Ownership Is Swelling
seekingalpha.com - February 22 at 10:54 AM |
| Krystal Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 22 at 10:54 AM |
| Krystal Biotech: Forget Botox, Is Gene Therapy The Answer To A Youthful Appearance?
seekingalpha.com - January 23 at 5:20 PM |
| Danforth Advisors entering Pittsburgh, focusing on life sciences sector
finance.yahoo.com - January 18 at 8:00 PM |
| Local gene therapy company opens in-house manufacturing facility
www.bizjournals.com - January 15 at 5:08 PM |
| Krystal Biotech Completes Construction of Ancoris - A New GMP Facility for Commercial Manufacturing of a Viral Vector-Based Gene Therapy to Treat Dystrophic Epidermolysis Bullosa
finance.yahoo.com - January 15 at 9:34 AM |
| Krystal Biotech: Update On KB103 Phase I Patients And Implications For Phase II
seekingalpha.com - December 31 at 4:24 PM |
